Skip to main content

Loading...

Media
< Back

Press Releases

Media Statements

Media Library
Our 2023 Integrated Annual Report is live!
Investors
Partnering
Careers

Loading...
English EN Français FR EN
- EnglishEN
- FrançaisFR
Global
< Back
- Global EN FR
- Annual Report EN FR
United States

Brazil

Canada

Mexico

Australia

China

Singapore

South Korea

Japan

Belgium

Ukraine

UK

Germany

France

Nordics

Greece

Italy

Netherlands

Spain

Poland

Russia

Czech Republic

Switzerland

Home
Company
Science
- Science
- Oncology
- Rare Disease
- Neuroscience
- Products
- R&D
- Pipeline
- Clinical Trials
- Lay Summaries
Sustainability
Patients
Stories

Home
Investors
Regulated Information

Regulated Information

Regulated Information
Shareholders Meeting

Filter

Period

Filter by

recent search

Reset

Showing: 1 – 05 of 107 Regulated Information

Show

Sort

No results available. Try modifying the filter criteria.

IPN price

€119.40

€-0.30 (-0.25%)

Media
Investors
Partnering
Careers

Company
Sustainability
Patients
Stories

Annual Report
Contact us

Terms and Conditions
Cookie Policy
Global Privacy Policy

Copyright © Ipsen Pharma. All rights reserved - 2025

You are now leaving the Ipsen group website. To continue, please click on Continue?